Bruce A Peacock- Venture Partner

Focus: Biotechnology

Summary:
Bruce Peacock joined SVLS in 2006. Bruce serves as the President and CEO of SVLSF III portfolio company Alba Therapeutics and sits on the Boards of portfolio companies Sapphire, Sadra Medical, Intranasal and NeurogesX as well as the public company Pharmacopeia.

Prior Experience:
He was most recently CEO of The Little Clinic, a start-up medical care services company, and prior to that served as president and CEO, and as a director of Adolor Corporation, a publicly traded biopharmaceutical products company focused on the development and commercialization of new therapies for pain management. While at Adolor Mr. Peacock gained the acceptance of the company's first New Drug Application, completed of a $100 million secondary offering and licensed a second clinical stage product. Prior to that, Mr. Peacock was the president, CEO and a director of Orthovita, Inc., a publicly traded orthopedic products company. He has also held senior management positions at Cephalon, Inc. and Centocor, Inc.

Qualifications:
Bruce received his BA from Villanova University in 1973 and his CPA in 1975.